Introduction {#JVEv4-sec-0005}
============

Hepatitis C virus (HCV) is an RNA virus and a member of the Flaviviridae family. It is most frequently transmitted parentally but vertically and sexually as well. HCV infection is of clinical significance due to its persistence in approximately 85% of infected individuals, posing a significant risk of subsequent chronic liver damage.

Its endemicity has long been established in Nigeria but there is a lack of information regarding its epidemiology [@JVEv4-bib-0001]. Various levels of HCV antibody prevalence in population subgroups have been reported in the country, although infrequently in teenagers, a subgroup we believe could benefit from surveillance, early detection and treatment. Here we report on the prevalence of HCV antibody among teenage university students in south-western Nigeria.

Materials and methods {#JVEv4-sec-0006}
=====================

This is a cross-sectional study involving 2406 teenage students at Babcock University, Ilisan-Remo, Ogun-State, Nigeria. They were 1084 males and 1322 females with a mean age of 17.3 years. Informed consent was obtained from all participants and ethical approval granted by the University authority.

We collected a venous blood sample (3 mL) and tested it for the presence of HCV antibody using LabACON chromatographic immunoassay test strips because of its availability. This assay has a sensitivity of 99.1% and a specificity of 99.5%. It was performed according to the manufacturer\'s instructions. Prevalence of HCV antibody in participants was expressed as percentages.

Results {#JVEv4-sec-0007}
=======

Table [1](#JVEv4-tbl-0001){ref-type="table"} shows that 18 of the 2406 participant blood samples were reactive for HCV antibody with no difference between males and females.

###### 

Prevalence of HCV antibody among teenage students

                           Reactive test N (%)   Non-Reactive test N (%)                 
  ------------------------ --------------------- ------------------------- ------------- -------------
  **Frequency *n* (%)**    09 (0.8)              09 (0.7)                  1075 (99.2)   1313 (99.3)
  **Prevalence *n* (%)**   18 (0.7)              2388 (99.3)                             

X^2^=0.67, df=1

Discussion {#JVEv4-sec-0008}
==========

It has long been known that HCV infection is endemic in Nigeria with variable prevalence rates reported among subgroups and regions [@JVEv4-bib-0002]. The 0.7% HCV antibody prevalence rate found in teenage university students in our study is lower than the overall prevalence of 2.1% recorded for Nigeria [@JVEv4-bib-0003]. This disparity may be due to the fact that our study targeted a young population subgroup, and also to the accuracy of the diagnostic method used to detect hepatitis C antibody. It has been documented that the immuno-chromatographic method (rapid test kit) is not sensitive enough to confirm HCV status in all cases [@JVEv4-bib-0004].

Similar studies within and outside our region have recorded a prevalence rate of 0.4% in Ogbomoso within our region [@JVEv4-bib-0005], a higher rate of 8% was found in Ilorin [@JVEv4-bib-0006] and no infections in Port Harcourt [@JVEv4-bib-0007]. The difference in seroprevalence between our study and previous reports in young people may be due to the number and age group of participants, and also to the prevailing cultural/traditional practices in different regions that could increase exposure to HCV.

There is no significant gender bias observed in the prevalence of hepatitis C virus in our study (X^2^=0.67, df=1), differing from a previous report where females were more susceptible to HCV than males [@JVEv4-bib-0006]; however, it is in agreement with the results obtained for the age range in a study conducted by Jemilohun *et al* within the same region [@JVEv4-bib-0001] and also in Port Harcourt where both genders exhibited a zero prevalence [@JVEv4-bib-0007].

Conclusion {#JVEv4-sec-0009}
==========

This study provides further evidence of a low HCV prevalence among young healthy teenage university students in Nigeria. Such data may help further in reducing the HCV burden in the country with appropriate preventative and therapeutic measures.
